Objectives To study trovafloxacin susceptibility among clinical isolates of four anaerobic bacterial species using minimum inhibitory concentrations (MIC) determinations, E test assays and disk diffusion test results and to calibrate the disk diffusion method for these species using single strain regression analysis (SRA).
INTRODUCTION
Among the newer fluoroquinolones, trovafloxaxcin (CP 99,219) shows improved efficacy not only against Gram-positive and Gram-negative aerobic organisms [1] [2] [3] but also against widely as it deserves [7] provided it can be calibrated properly [8] . The present studies were performed to evaluate a calibration method for trovafloxacin susceptibility testing of anaerobic isolates and to study trovafloxacin susceptibility among rapidly growing anaerobes in Sweden using minimum inhibitory concentration (MIC) testing with the agar dilution method, MIC estimation using the E test and the calibrated disk diffusion method.
MATERIALS AND METHODS

Bacterial strains
Clinical isolates of anaerobic bacteria were collected from routine specimens received at the Clinical Microbiology Laboratory, University Hospital of Lund, Lund, Sweden. The 187 strains included 89 isolates of Bacteroides fragilis, 22 isolates of Bacteroides thetaiotaomicron, 41 isolates of Clostridium perfringens, and 35 strains of Peptostreptococcus magnus. Species identification followed established procedures [9, 10] . All strains were subcultured and stored on Fastidious anaerobe agar (Lab M, Topley House, Wash Lane, Bury, England) in Gas Pack jars (BBL) at room temperature until testing. The strains had experienced 2-4 passages before testing. Control strains Bacteroides fragilis, ATCC 25285, Bacteroides thetaiotaomicron, ATCC 29741, Clostridium perfringens, ATCC 13124, and Peptostreptococcus magnus, ATCC 29328, were included for MIC determinations and disk diffusion tests and also for single-strain regression analysis (SRA) to calibrate the disk test.
MIC determinations
The MIC of trovafloxacin for clinical isolates of anaerobic pathogens and for control strains was determined using the agar dilution method [11] . MICs were determined by incorporating the antibiotics in PDM agar medium (AB Biodisk, Solna, Sweden) supplemented with 5% horse blood, vitamin K, and hemin. Supplemented PDM agar plates containing two-fold dilutions of trovafloxacin were prepared and used on the same day. The inoculum was prepared by suspending colonies from a 48 h culture plate into Fastidious anaerobe broth (F.A.B. Lab 71; Lab M, ) to a visible turbidity of a no. 0.5 McFarland standard. Using a Steers' replicator, 10 mL of the bacterial suspension was applied to the plate with a final inoculum of approximately 10 5 CFU per spot. The plates were incubated at 35-37°C in an anaerobic cabinet for 48 h. The MIC was defined as the lowest concentration of antibiotic that inhibited visible growth.
MIC limits for interpretation of susceptibility were S ¾ 1.0, R − 4.0 mg/L for trovafloxacin according to Swedish Reference Group for Antibiotics (SRGA) or S ¾ 2.0, R − 8.0 mg/L according to NCCLS recommendations. The German DIN guidelines recommend S ¾ 1.0, R − 4.0 mg/L, but other German studies favour S ¾ 2.0, R − 8.0 mg/L [12] . MIC 50 and MIC 90 values for populations of strains represent the MIC of 50% and 90% of the strains, respectively. When MIC-values constituted a single homogeneous population and included more than two dilution values, the MIC 50 and MIC 90 values were also calculated using probit analysis of the distribution for more exact intrapolation [13] . These values are called MIC 50P and MIC 90P .
E test
For the E test (AB Biodisk), prereduced supplemented PDM plates were used. The inoculum (approximately 10 8 CFU/mL) was the same as used for the agar dilution tests. The inoculum was applied with a sterile cotton swab streaked in two crossing directions and then allowed to be absorbed for 10 min before the antibiotic strip was applied. The plates were incubated at 35-37°C in an anaerobic cabinet and evaluated after 24 and 48 h. The MIC was read from the scale at the intersection of the zone with the strip according to the instructions of the manufacturer.
Disk diffusion antibiotic susceptibility testing
The antibiotic susceptibility of clinical isolates was determined by the disk diffusion method according to SRGA [11] with interpretations adjusted for species groups when applicable [14, 15] . Suspensions of the bacterial isolates were inoculated on prereduced supplemented PDM agar using cotton swabs streaked on the medium in two crossing directions. The inoculum (approximately 10 8 CFU/mL) was the same as used for the agar dilution tests and the E tests. After absorption of the inoculum, the antibiotic disks were applied followed by preincubation at room temperature for 15-20 min. The plates were then incubated at 35-37°C in an anaerobic cabinet and evaluated after 24 and 48 h.
Both SRGA and NCCLS recommend a trovafloxacin disk content of 10 mg whereas German DIN propose a 5-mg disk [12] . Trovafloxacin disks were provided by Pfizer AB (Täby, Sweden). Inhibition zone diameter values were read with a pair of calipers, in millimetres to one decimal place. Zone diameter values were plotted species-wise for the different antibiotics as histograms with zone values (as integers) on the X-axis and per cent strains on the Y-axis [16, 17] .
Single strain regression analysis
Antibiotic disks were produced with five different trovafloxacin disk contents: 1, 3, 10, 30, and 100 mg. The production of these disks followed methods used since the 1960s in the Karolinska hospital laboratory [18] . The four control strains were tested against these disks five to eight times (five times is recommended, three is a minimum) on different occasions. The test procedure for SRGA disk tests followed the recommendations for regular disk diffusion tests [11, 15, 19] . It is emphasized that SRA should be performed using exactly the same procedure as the routine disk tests in order to truly reflect the routine test results for correct calibration. Trovafloxacin MIC values for the reference strains were determined by repeated tests on different occasions by the agar dilution method according to SRGA standardization as described above. SRA equation constants A and B were calculated using computer software. Constants A and B for the four reference strains were then used for calculations of interpretive zone breakpoints corresponding to MIC limits set for the susceptibility categories. The zone diameter equivalents to MIC values on either side of the S, susceptible, or R, resistant, limit were calculated and the mean value of these inhibition zones around the limit were then adjusted to the nearest higher integer for the S-limit and to the nearest lower integer for the R-limit, as described earlier [20] .
Evaluation of zone breakpoints
The evaluation of inhibition zone breakpoints for the susceptibility categories, S, I, and R, was performed using error rating according to NCCLS. Minor discrepancy is defined as an intermediate result by one method and either susceptible or resistant by the other. Major discrepancy is defined as a true susceptible result but resistance according to the other method. A very major discrepancy is a true resistant result which is read as susceptible by the disk diffusion method. The rates of these discrepancies were calculated for the different species and the MIC values from agar dilution tests compared with interpret- Table 1 Results of trovafloxacin minimum inhibitory concentration (MIC) determinations using the agar dilution method and the E test. The susceptibility rate was determined according to NCCLS MIC limits, S ¾ 2.0, R − 8.0 mg/L, for anaerobic isolates of four different species, and expressed as per cent susceptible (S + I) strains (actual numbers out of total number of isolates shown in parenthesis) 0.59, 0.70, and 0.83, for isolates belonging to the four species, respectively.
Calibration of the disk diffusion method
Since the disk diffusion test is a more practical alternative to MIC determinations in clinical microbiology, we applied SRGA standardization of the disk diffusion method for testing anaerobic bacterial isolates included in our studies. The 10-mg trovafloxacin disk diffusion test was first calibrated as follows. SRA calculations were performed for the four reference strains of the four anaerobic species included. These experiments showed that the regression lines for the four reference strains were slightly different ( Figure 1 ). Bacteroides fragilis and C. perfringens gave slope constants which were lower than the slope constants for the other two species, B. thetaiotaomicron and P. magnus ( Table 2 ). The zone diameter equivalents of MIC values around the MIC limits for the susceptibility categories were then calculated ( Table 2 ). Corresponding to the differences in regression lines, the calculated zone breakpoints differed between the four species by up to 5-6 mm ( Table 2 ). In order to apply these zone breakpoints to the present studies, the inhibition zone diameter values from disk testing of the 187 clinical isolates were plotted against the corresponding MIC values. For the Bacteroides iso- 
Disk diffusion test results
Using the NCCLS limits, the application of the calculated zone breakpoints for a 10-mg trovafloxacin disk ( [24] . However, the calculation of interpretive breakpoints using SRA provided an accurate reflection of the present interpretive MIC limits and the method therefore offers a new tool for the individual laboratory to set up a standardized and calibrated disk diffusion method also for anaerobic bacteria.
Choice of disk content for routine disk diffusion testing
The SRA calculations also permit a theoretical consideration of various disk contents for testing of anaerobes in clinical microbiology. The basic criterion is given above under Materials and Methods and it requires that measurable zones are produced around the disk by all species for all S and I isolates [22] . The inhibition zones corresponding to the NCCLS limit for resistance, 8 mg/L, are shown in Figure 2 for the four species and for different disk contents. It is clear that neither B. fragilis nor C. perfringens isolates would pose any problems (Figure 2) . However, the more steep regression lines for the other two species (Figure 1) give almost no zones for MIC 8 mg/L with a 2 mg trovafloxacin disk (Figure 2 ). The 5 mg disk would be able to give zones for intermediate strains (4 mg/L) of B. thetaiotaomicron taking into account a methodological variation of 21 MIC dilution steps. Peptostreptococcus magnus isolates would be less critical. A 10-mg disk would be safer without introducing too large zones for more susceptible isolates. For testing anaerobes belonging to the species studied, both the 5 and the 10 mg disks should produce accurate results.
DISCUSSION
Trovafloxacin is a fluoroquinolone antibiotic which is active against anaerobic human pathogens [5, 6, 25] . This was also shown in the present studies where 98.9, 100, 100, and 97% of B. fragilis, B. thetaiotaomicron, C. perfringens, and P. magnus strains, respectively, were susceptible (S + I) as judged by MIC determinations. Trovafloxacin compares well with other potent antibiotic drugs, but has a broader range of action than most other fluoroquinolone drugs. It might be used as monotherapy in intra-abdominal infections, which often start off with aerobic Enterobacteriacae such as E. coli, and then switch to obligate anaerobes such as B. fragilis in a second phase. Its proper place in the anti-infective arsenal remains to be seen. Standardization of antibiotic susceptibility testing of nonfastidious aerobic isolates using the disk diffusion method has been well supported by several reference authorities over the years. Similar efforts have been largely lacking when it comes to disk diffusion testing of anaerobes. However, studies have shown promising results for disk testing of rapidly growing anaerobes [7, 8] . Also, trovafloxacin disk diffusion tests of anaerobes has been described [25] . Since the major problem with disk testing is associated with deviations from the reference laboratory in methodology as well as in performance of individual bacterial species, the accuracy of the disk test can be improved with laboratory-specific regression lines and speciesrelated interpretations [14, 15, 17, 24] . We have therefore used SRA to calibrate the disk diffusion test for the four different anaerobic species studied [15, 19] . The SRA experiments permitted the calculation of interpretive zone breakpoints according to recommended MIC limits (NCCLS) and according to species-specific regression lines.
When a new antibiotic is introduced it is necessary to determine which disk content should be used for routine disk diffusion tests in microbiology laboratories. Usually, different contents of antibiotic are tested and their performance evaluated using a panel of clinical isolates. However, no clear criteria for the optimal choice have been defined. We have used a recently presented definition of the optimal disk content of antibioticthe lowest disk content of antibiotic which will distinguish resistant strains from those of the intermediate or susceptible category [22] . This definition is possible to apply with the aid of SRA calculations. Our results showed that it would be possible to use a 5-mg trovafloxacin disk. However, considering some residual variation in laboratory performance, the 10-mg trovafloxacin disk would be safer without giving rise to too large inhibition zones for susceptible isolates. Both disk contents have been advocated by others [12, 25] .
The trovafloxacin MIC results for Bacteroides isolates showed that MIC 50 and MIC 90 , 0.5 and 1-2 mg/L, respectively, were close to the interpretive limits, S ¾ 2.0, R − 8.0 mg/L. It was therefore postulated that interpretive errors of type I might occur when performing disk diffusion tests [24] . Such was actually the case and it was concluded that the MIC limits for Bacteroides isolates should be species-related. However, even without such corrective measures, which also have been advocated and implemented by SRGA, the susceptibility figures were in line with the favourable activity of trovafloxacin according to MIC values (Tables 1, 2 ) [14, 24] . Another situation which might require species-related interpretive MIClimits, is not of a strict methodological nature. Clostridium perfringens isolates showed an MIC 50 value of 0.125 mg/L, which is much lower than the MIC limit of S ¾ 2.0 mg/L. If some resistance mechanism gives a 10-fold rise in the MIC, then the strain will still be labelled trovafloxacin susceptible. It is not advisable to recommend the drug in such a situation. A lowering of the MIC limit for this bacterial species might safeguard against such abuse.
A small but consistent discrepancy between MIC results from agar dilution tests and E test estimations was noted. The E test values were always lower, down to 50% of the reference MIC values. Such discrepancies have been described by several authors for other antibiotics and aerobic as well as anaerobic isolates [26] [27] [28] , both towards higher values [29] [30] [31] and lower values [32, 33] . Basically, the E test is a diffusion method and it was originally described and patented by Professor Olof Vesterberg (Swedish Patent no. 403 382) and then developed by Biodisk AB to a commercial product [34] . It consists of a continuous gradient of antibiotic and it is widely used for susceptibility testing of anaerobes [26, 27, 33, [35] [36] [37] . Since both the E test and the disk test are diffusion methods, it is clear that whenever the E test can be used, it should also be possible to apply the regular disk diffusion test. This is particularly true when interpretive zone breakpoints can be set for anaerobes and other fastidious species by calibration of the disk test in the laboratory using SRA.
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